Government of Canada with a flag logo

Psilocybin and Psilocin (Magic Mushrooms) – Government of Canada

The Government of Canada’s official stance on the legal status of Psilocybin containing substances in the Country

Photo of Law Book, Scale and Mallet

In this article, the Government of Canada addresses the use of “magic mushrooms,” emphasizing their illegal status in the country.

The piece explores the hallucinogenic compounds within these mushrooms, primarily psilocybin and detailing their short-term and potential long-term effects.

Despite their prohibition, the government acknowledges the growing interest in psilocybin’s therapeutic potential, particularly in treating mental health disorders like anxiety and depression. However, it underscores that, currently, there are no approved therapeutic products containing psilocybin in Canada.

The article also outlines the risks associated with magic mushroom use and provides insights into the regulatory landscape, highlighting legal avenues for accessing psilocybin for therapeutic purposes, including clinical trials, the Special Access Program, and individual exemptions from the Controlled Drugs and Substances Act (CDSA).

Overall, the article offers a concise overview of Canada’s perspective on magic mushrooms, covering their effects, legal status, and the evolving research landscape.